Start over in India! During the last decade, oncology research has undergone progressive globalization. It was estimated that an average of one million new cases of cancer are reported every year from India. Big Pharma in recent years is focussing on the conduct of oncology research in India. The country offers 700000 speciality sites, 221 medical colleges with trained and experienced English speaking medical staff and personal and state-of-an-art facilities and infrastructure for the conduct of oncology clinical trials in the country. The increase in medical tourism to India from the West supports the fact that India has state-of-an-art medical facilities and experienced medical staff.
Reasons for Clinical Trial Outsourcing to India
The various reasons for outsourcing clinical trials to India from the West:
• High rate of subject recruitment (nearly 7 times than in US)
• Treatment nave patient pool
• Occurrence of large number of cancer cases
• Huge unmet medical need
• Presence of high productive clinical trial sites
• Availability of skilful and trained investigators
• Increased standard of care
• Availability of cancer registries and databases
• Availability of stipulate regulations and regulatory bodies